A once-weekly prophylactic treatment of this investigational agent led to normal or near-normal factor VIII activity levels in most patients with severe hemophilia A.
A new treatment that helps people with hemophilia A maintain higher levels of a crucial blood clotting factor with fewer treatments is a victory for patients, according to a new editorial in The New England Journal of Medicine this week by Dr. Cindy Leissinger, director of the Louisiana Center for Bleeding and Clotting Disorders at Tulane University School of Medicine.
Cure 4 The Kids Foundation Announces Promotion of Dr. Aimee Foord nevadabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nevadabusiness.com Daily Mail and Mail on Sunday newspapers.
In Partnership with Global Genes, Bleeding Disorders Alliance Illinois Hosts Inaugural Ultra-RARE Bleeding Disorder Meet-Up Conference globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.